Shockwave Medical, Inc.
SWAV
$330.49
$0.490.15%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 49.11% | 56.15% | 69.52% | 86.42% | 106.51% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 49.11% | 56.15% | 69.52% | 86.42% | 106.51% |
| Cost of Revenue | 46.76% | 45.58% | 52.04% | 57.58% | 56.85% |
| Gross Profit | 49.47% | 57.87% | 72.52% | 91.73% | 117.03% |
| SG&A Expenses | 49.87% | 47.85% | 51.54% | 49.41% | 49.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 55.67% | 53.31% | 54.06% | 53.09% | 53.60% |
| Operating Income | 29.77% | 66.09% | 145.16% | 364.47% | 14,351.89% |
| Income Before Tax | 44.24% | 83.22% | 173.52% | 398.80% | 1,467.61% |
| Income Tax Expenses | 128.37% | -6,828.79% | -7,925.54% | -20,750.44% | -31,717.28% |
| Earnings from Continuing Operations | -31.81% | 177.06% | 343.68% | 730.06% | 2,464.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.81% | 177.06% | 343.68% | 730.06% | 2,464.23% |
| EBIT | 29.77% | 66.09% | 145.16% | 364.47% | 14,351.89% |
| EBITDA | 32.92% | 67.91% | 140.85% | 330.70% | 4,663.29% |
| EPS Basic | -33.01% | 172.66% | 336.09% | 714.23% | 2,327.07% |
| Normalized Basic EPS | 42.91% | 80.36% | 168.39% | 389.38% | 1,390.10% |
| EPS Diluted | -32.14% | 174.77% | 338.07% | 720.59% | 2,008.31% |
| Normalized Diluted EPS | 44.87% | 82.44% | 170.78% | 395.19% | 1,214.65% |
| Average Basic Shares Outstanding | 2.24% | 2.31% | 2.33% | 2.31% | 2.29% |
| Average Diluted Shares Outstanding | 0.86% | 1.01% | 1.10% | 2.55% | 4.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
